Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Management of high-risk acute pulmonary embolism : an emulated target trial analysis
Avtorji:ID Stadlbauer, Andrea (Avtor)
ID Verbelen, Tom (Avtor)
ID Binzenhöfer, Leonhard (Avtor)
ID Goslar, Tomaž (Avtor)
ID Supady, Alexander (Avtor)
ID Spieth, Peter M. (Avtor)
ID Noč, Marko (Avtor)
ID Verstraete, Andreas (Avtor)
ID Hoffmann, Sabine (Avtor)
ID Schomaker, Michael (Avtor), et al.
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,22 MB)
MD5: 88769A0A5F33CB9E11BE07A2C9B8034A
 
URL URL - Izvorni URL, za dostop obiščite https://link.springer.com/article/10.1007/s00134-025-07805-4
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:Background: High-risk acute pulmonary embolism (PE) is a life-threatening condition necessitating hemodynamic stabilization and rapid restoration of pulmonary perfusion. In this context, evidence regarding the benefit of advanced circulatory support and pulmonary recanalization strategies is still limited. Methods: In this observational study, we assessed data of 1060 patients treated for high-risk acute PE with 991 being included in a target trial emulation to investigate all-cause in-hospital mortality estimates with different advanced treatment strategies. The four treatment groups consisted of patients undergoing (I) veno-arterial extracorporeal membrane oxygenation (VA-ECMO) alone (n = 126), (II) intrahospital systemic thrombolysis (SYS) (n = 643), (III) surgical thrombectomy (ST) (n = 49), and (IV) percutaneous catheter-directed treatment (PCDT) (n = 173). VA-ECMO was allowed as bridging to pulmonary recanalization in groups II, III, and IV. Marginal causal contrasts were estimated using the g-formula with logistic regression models as the primary approach. Sensitivity analyses included targeted maximum likelihood estimation (TMLE) with machine learning, inverse probability of treatment weighting (IPTW), as well as variations of estimands, handling of missing values, and a complete target trial emulation excluding the VA-ECMO alone group. Results: In the overall target trial population, the median age was 62.0 years, and 53.3% of patients were male. The estimated probability of in-hospital mortality from the primary target trial intention-to-treat analysis for VA-ECMO alone was 57% (95% confidence interval [CI] 47%; 67%), compared to 48% (95% CI 44%; 53%) for intrahospital SYS, 34% (95%CI 18%; 50%) for ST, and 43% (95% CI 35%; 51%) for PCDT. The mortality risk ratios were largely in favor of any advanced recanalization strategy over VA-ECMO alone. The robustness of these findings was supported by all sensitivity analyses. In the crude outcome analysis, patients surviving to discharge had a high probability of favorable neurologic outcome in all treatment groups. Conclusion: Advanced recanalization by means of SYS, ST, and several promising catheter-directed systems may have a positive impact on short-term survival of patients presenting with high-risk PE compared to the use of VA-ECMO alone as a bridge to recovery.
Ključne besede:high-risk pulmonary embolism, mechanical circulatory support, percutaneous catheter-directed treatment, surgical thrombectomy, systemic thrombolysis
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:str. 490-505
Številčenje:Vol. 51, iss. 3
PID:20.500.12556/DiRROS-28950 Novo okno
UDK:616.1
ISSN pri članku:0342-4642
DOI:10.1007/s00134-025-07805-4 Novo okno
COBISS.SI-ID:241085443 Novo okno
Opomba:
Datum objave v DiRROS:14.04.2026
Število ogledov:111
Število prenosov:77
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Intensive care medicine
Skrajšan naslov:Intensive Care Med
Založnik:Springer
ISSN:0342-4642
COBISS.SI-ID:6315015 Novo okno

Gradivo je financirano iz projekta

Financer:Drugi - Drug financer ali več financerjev
Številka projekta:-
Naslov:DEAL
Akronim:DEAL

Licence

Licenca:CC BY-NC 4.0, Creative Commons Priznanje avtorstva-Nekomercialno 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc/4.0/deed.sl
Opis:Licenca Creative Commons, ki prepoveduje komercialno uporabo, vendar uporabniki ne rabijo upravljati materialnih avtorskih pravic na izpeljanih delih z enako licenco.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:visokorizična pljučna embolija, mehanska podpora krvnega obtoka, perkutano katetrsko usmerjeno zdravljenje, kirurška trombektomija, sistemska tromboliza


Nazaj